Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumitrace for Intraoperative Ureter Visualization in Abdominopelvic Surgeries
NCT07080008Phase 1Active, not recruiting
- Sponsor
- MediBeacon
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of relmapirazin in ureter injury, sponsored by MediBeacon. Primary endpoint: Intra-participant difference in laparoscopic view of ureter conspicuity for white light (WL) versus fluorescence (BLUE). Started Jan 2026; status: active, not recruiting.
02
Drugs
relmapirazin
03
Conditions
ureter injury
Beyond the preview
Go deeper on NCT07080008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07080008.